| Trial ID: | L4108 |
| Source ID: | NCT06104358
|
| Associated Drug: |
Hu6
|
| Title: |
Ph 2a Study of HU6 on Energy Metabolism, Muscle and Liver Substrate Metabolism, and Mitochondrial Function in Subjects Who Are Overweight or Obese With Type 2 Diabetes
|
| Acronym: |
|
| Status: |
WITHDRAWN
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Diabete Type 2|Obesity
|
| Interventions: |
DRUG: HU6
|
| Outcome Measures: |
Primary: Sleeping Metabolic Rate (SMR) change from Baseline to 6 Months (26 weeks), Change from baseline in SMR at 6 months (26 weeks) as assessed by whole room indirect calorimetry (WRIC)., 26 weeks |
|
| Sponsor/Collaborators: |
Sponsor: Rivus Pharmaceuticals, Inc.
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE2
|
| Enrollment: |
0
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
|
| Start Date: |
2023-11-17
|
| Completion Date: |
2025-03
|
| Results First Posted: |
|
| Last Update Posted: |
2024-01-09
|
| Locations: |
AdventHealth Translational Research Institute, Orlando, Florida, 32804, United States
|
| URL: |
https://clinicaltrials.gov/show/NCT06104358
|
